These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
502 related articles for article (PubMed ID: 34611967)
1. Genetic liability for substance use associated with medical comorbidities in electronic health records of African- and European-ancestry individuals. Hartwell EE; Merikangas AK; Verma SS; Ritchie MD; ; Kranzler HR; Kember RL Addict Biol; 2022 Jan; 27(1):e13099. PubMed ID: 34611967 [TBL] [Abstract][Full Text] [Related]
2. Phenome-wide Association Analysis of Substance Use Disorders in a Deeply Phenotyped Sample. Kember RL; Hartwell EE; Xu H; Rotenberg J; Almasy L; Zhou H; Gelernter J; Kranzler HR Biol Psychiatry; 2023 Mar; 93(6):536-545. PubMed ID: 36273948 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci. Deak JD; Zhou H; Galimberti M; Levey DF; Wendt FR; Sanchez-Roige S; Hatoum AS; Johnson EC; Nunez YZ; Demontis D; Børglum AD; Rajagopal VM; Jennings MV; Kember RL; Justice AC; Edenberg HJ; Agrawal A; Polimanti R; Kranzler HR; Gelernter J Mol Psychiatry; 2022 Oct; 27(10):3970-3979. PubMed ID: 35879402 [TBL] [Abstract][Full Text] [Related]
4. Application of polygenic scores to a deeply phenotyped sample enriched for substance use disorders reveals extensive pleiotropy with psychiatric and somatic traits. Hartwell EE; Jinwala Z; Milone J; Ramirez S; Gelernter J; Kranzler HR; Kember RL Neuropsychopharmacology; 2024 Dec; 49(13):1958-1967. PubMed ID: 39043921 [TBL] [Abstract][Full Text] [Related]
5. Identifying genetic loci and phenomic associations of substance use traits: A multi-trait analysis of GWAS (MTAG) study. Xu H; Toikumo S; Crist RC; Glogowska K; Jinwala Z; Deak JD; Justice AC; Gelernter J; Johnson EC; Kranzler HR; Kember RL Addiction; 2023 Oct; 118(10):1942-1952. PubMed ID: 37156939 [TBL] [Abstract][Full Text] [Related]
6. Does polygenic risk for substance-related traits predict ages of onset and progression of symptoms? Kranzler HR; Feinn R; Xu H; Ho BL; Saini D; Nicastro OR; Jacoby A; Toikumo S; Gelernter J; Hartwell EE; Kember RL Addiction; 2023 Sep; 118(9):1675-1686. PubMed ID: 37069489 [TBL] [Abstract][Full Text] [Related]
8. Polygenic Risk of Psychiatric Disorders Exhibits Cross-trait Associations in Electronic Health Record Data From European Ancestry Individuals. Kember RL; Merikangas AK; Verma SS; Verma A; Judy R; ; Damrauer SM; Ritchie MD; Rader DJ; Bućan M Biol Psychiatry; 2021 Feb; 89(3):236-245. PubMed ID: 32919613 [TBL] [Abstract][Full Text] [Related]
9. Association between polygenic risk for tobacco or alcohol consumption and liability to licit and illicit substance use in young Australian adults. Chang LH; Couvy-Duchesne B; Liu M; Medland SE; Verhulst B; Benotsch EG; Hickie IB; Martin NG; Gillespie NA; Drug Alcohol Depend; 2019 Apr; 197():271-279. PubMed ID: 30875648 [TBL] [Abstract][Full Text] [Related]
11. Associations between polygenic risk for tobacco and alcohol use and liability to tobacco and alcohol use, and psychiatric disorders in an independent sample of 13,999 Australian adults. Chang LH; Whitfield JB; Liu M; Medland SE; Hickie IB; Martin NG; Verhulst B; Heath AC; Madden PA; Statham DJ; Gillespie NA; Drug Alcohol Depend; 2019 Dec; 205():107704. PubMed ID: 31731259 [TBL] [Abstract][Full Text] [Related]
12. Polygenic risk score-based phenome-wide association study of head and neck cancer across two large biobanks. Lee YC; Jung SH; Shivakumar M; Cha S; Park WY; Won HH; Eun YG; Biobank PM; Kim D BMC Med; 2024 Mar; 22(1):120. PubMed ID: 38486201 [TBL] [Abstract][Full Text] [Related]
13. Associations between attention-deficit hyperactivity disorder genetic liability and ICD-10 medical conditions in adults: utilizing electronic health records in a Phenome-Wide Association Study. Haan E; Krebs K; Võsa U; Brikell I; Larsson H; ; Lehto K Psychol Med; 2024 Jul; 54(10):2468-2481. PubMed ID: 38563284 [TBL] [Abstract][Full Text] [Related]
14. Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study. Zhou H; Rentsch CT; Cheng Z; Kember RL; Nunez YZ; Sherva RM; Tate JP; Dao C; Xu K; Polimanti R; Farrer LA; Justice AC; Kranzler HR; Gelernter J; JAMA Psychiatry; 2020 Oct; 77(10):1072-1080. PubMed ID: 32492095 [TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic contributions to medical comorbidity in bipolar disorder: a study using electronic health records-linked biobank data. Sanchez-Ruiz JA; Coombes BJ; Pazdernik VM; Melhuish Beaupre LM; Jenkins GD; Pendegraft RS; Batzler A; Ozerdem A; McElroy SL; Gardea-Resendez MA; Cuellar-Barboza AB; Prieto ML; Frye MA; Biernacka JM Mol Psychiatry; 2024 Sep; 29(9):2701-2713. PubMed ID: 38548982 [TBL] [Abstract][Full Text] [Related]
16. Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics Initiative. Fritsche LG; Gruber SB; Wu Z; Schmidt EM; Zawistowski M; Moser SE; Blanc VM; Brummett CM; Kheterpal S; Abecasis GR; Mukherjee B Am J Hum Genet; 2018 Jun; 102(6):1048-1061. PubMed ID: 29779563 [TBL] [Abstract][Full Text] [Related]
17. A Polygenic and Phenotypic Risk Prediction for Polycystic Ovary Syndrome Evaluated by Phenome-Wide Association Studies. Joo YY; Actkins K; Pacheco JA; Basile AO; Carroll R; Crosslin DR; Day F; Denny JC; Velez Edwards DR; Hakonarson H; Harley JB; Hebbring SJ; Ho K; Jarvik GP; Jones M; Karaderi T; Mentch FD; Meun C; Namjou B; Pendergrass S; Ritchie MD; Stanaway IB; Urbanek M; Walunas TL; Smith M; Chisholm RL; Kho AN; Davis L; Hayes MG; J Clin Endocrinol Metab; 2020 Jun; 105(6):1918-36. PubMed ID: 31917831 [TBL] [Abstract][Full Text] [Related]
18. Polygenic Scores for Major Depressive Disorder and Risk of Alcohol Dependence. Andersen AM; Pietrzak RH; Kranzler HR; Ma L; Zhou H; Liu X; Kramer J; Kuperman S; Edenberg HJ; Nurnberger JI; Rice JP; Tischfield JA; Goate A; Foroud TM; Meyers JL; Porjesz B; Dick DM; Hesselbrock V; Boerwinkle E; Southwick SM; Krystal JH; Weissman MM; Levinson DF; Potash JB; Gelernter J; Han S JAMA Psychiatry; 2017 Nov; 74(11):1153-1160. PubMed ID: 28813562 [TBL] [Abstract][Full Text] [Related]
19. Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores. Vilar-Ribó L; Cabana-Domínguez J; Alemany S; Llonga N; Arribas L; Grau-López L; Daigre C; Cormand B; Fernàndez-Castillo N; Ramos-Quiroga JA; Soler Artigas M; Ribasés M Transl Psychiatry; 2024 May; 14(1):221. PubMed ID: 38811559 [TBL] [Abstract][Full Text] [Related]
20. Psychosocial moderation of polygenic risk for cannabis involvement: the role of trauma exposure and frequency of religious service attendance. Meyers JL; Salvatore JE; Aliev F; Johnson EC; McCutcheon VV; Su J; Kuo SI; Lai D; Wetherill L; Wang JC; Chan G; Hesselbrock V; Foroud T; Bucholz KK; Edenberg HJ; Dick DM; Porjesz B; Agrawal A Transl Psychiatry; 2019 Oct; 9(1):269. PubMed ID: 31636251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]